The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer

por Long, Mark D., Smiraglia, Dominic J., Campbell, Moray J.
Publicado 2017

Dynamic patterns of DNA methylation in the normal prostate epithelial differentiation program are targets of aberrant methylation in prostate cancer

por Long, Mark D., Dhiman, Vineet K., Affronti, Hayley C., Hu, Qiang, Liu, Song, Smiraglia, Dominic J.
Publicado 2021

Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling

por Makino, Kenichi, Long, Mark D, Kajihara, Ryutaro, Matsueda, Satoko, Oba, Takaaki, Kanehira, Kazunori, Liu, Song, Ito, Fumito
Publicado 2022

JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy

por Rosario, Spencer R., Jacobi, Justine J., Long, Mark D., Affronti, Hayley C., Rowsam, Aryn M., Smiraglia, Dominic J.
Publicado 2023

Integrative genomic analysis in K562 chronic myelogenous leukemia cells reveals that proximal NCOR1 binding positively regulates genes that govern erythroid differentiation and Ima...

por Long, Mark D., van den Berg, Patrick R., Russell, James L., Singh, Prashant K., Battaglia, Sebastiano, Campbell, Moray J.
Publicado 2015

Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s

por Oba, Takaaki, Long, Mark D., Keler, Tibor, Marsh, Henry C., Minderman, Hans, Abrams, Scott I., Liu, Song, Ito, Fumito
Publicado 2020

Identification of transcription factor co-regulators that drive prostate cancer progression

por Siddappa, Manjunath, Wani, Sajad A., Long, Mark D., Leach, Damien A., Mathé, Ewy A., Bevan, Charlotte L., Campbell, Moray J.
Publicado 2020

MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells

por Hagiwara, Masayuki, Fushimi, Atsushi, Yamashita, Nami, Bhattacharya, Atrayee, Rajabi, Hasan, Long, Mark D., Yasumizu, Yota, Oya, Mototsugu, Liu, Song, Kufe, Donald
Publicado 2021

MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression

por Bhattacharya, Atrayee, Fushimi, Atsushi, Wang, Keyi, Yamashita, Nami, Morimoto, Yoshihiro, Ishikawa, Satoshi, Daimon, Tatsuaki, Liu, Tao, Liu, Song, Long, Mark D., Kufe, Donald
Publicado 2023

MUC1-C REPRESSES THE RASSF1A TUMOR SUPPRESSOR IN HUMAN CARCINOMA CELLS

por Rajabi, Hasan, Hata, Tsuyoshi, Li, Wei, Long, Mark D, Hu, Qiang, Liu, Song, Raina, Deepak, Kui, Ling, Hong, Deli, Samur, Mehmet, Kufe, Donald
Publicado 2019

Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer

por Yamashita, Nami, Fushimi, Atsushi, Morimoto, Yoshihiro, Bhattacharya, Atrayee, Hagiwara, Masayuki, Yamamoto, Masaaki, Hata, Tsuyoshi, Shapiro, Geoffrey I., Long, Mark D., Liu, Song, Kufe, Donald
Publicado 2022

Correction: MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells

por Rajabi, Hasan, Hata, Tsuyoshi, Li, Wei, Long, Mark D., Hu, Qiang, Liu, Song, Raina, Deepak, Kui, Ling, Yasumizu, Yota, Hong, Deli, Samur, Mehmet, Kufe, Donald
Publicado 2019

Position‐Scanning Peptide Libraries as Particle Immunogens for Improving CD8(+) T‐Cell Responses

por He, Xuedan, Zhou, Shiqi, Quinn, Breandan, Huang, Wei‐Chiao, Jahagirdar, Dushyant, Vega, Michael, Ortega, Joaquin, Long, Mark D., Ito, Fumito, Abrams, Scott I., Lovell, Jonathan F.
Publicado 2021

Predictive and Prognostic Implications of Circulating CX3CR1(+) CD8(+) T Cells in Non–Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy

por Abdelfatah, Eihab, Long, Mark D., Kajihara, Ryutaro, Oba, Takaaki, Yamauchi, Takayoshi, Chen, Hongbin, Sarkar, Joy, Attwood, Kristopher, Matsuzaki, Junko, Segal, Brahm H., Dy, Grace K., Ito, Fumito
Publicado 2023

MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells

por Bhattacharya, Atrayee, Fushimi, Atsushi, Yamashita, Nami, Hagiwara, Masayuki, Morimoto, Yoshihiro, Rajabi, Hasan, Long, Mark D., Abdulla, Maha, Ahmad, Rehan, Street, Kelly, Liu, Song, Liu, Tao, Kufe, Donald
Publicado 2022

MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells

por Yamashita, Nami, Withers, Henry, Morimoto, Yoshihiro, Bhattacharya, Atrayee, Haratake, Naoki, Daimon, Tatsuaki, Fushimi, Atsushi, Nakashoji, Ayako, Thorner, Aaron R., Isenhart, Emily, Rosario, Spencer, Long, Mark D., Kufe, Donald
Publicado 2023

The MYC axis in advanced prostate cancer is impacted through concurrent targeting of ERβ and AR using a novel ERβ-selective ligand alongside Enzalutamide

por Gray, Jaimie S., Wani, Sajad A., Hussain, Shahid, Huang, Phoebe, Nayak, Debasis, Long, Mark D., Yates, Clayton, Clinton, Steven K., Bennet, Chad E., Coss, Christopher C., Campbell, Moray J.
Publicado 2023

Concurrent Aspirin Use Is Associated with Improved Outcome in Rectal Cancer Patients Who Undergo Chemoradiation Therapy

por Farrugia, Mark K., Long, Mark D., Mattson, David M., Flaherty, Leayn T., Dong, Bowen, Cortes Gomez, Eduardo, Wei, Lei, Witkiewicz, Agnieszka K., Yao, Song, Kalinski, Pawel, Singh, Anurag K.
Publicado 2021

MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer

por Hagiwara, Masayuki, Fushimi, Atsushi, Bhattacharya, Atrayee, Yamashita, Nami, Morimoto, Yoshihiro, Oya, Mototsugu, Withers, Henry G., Hu, Qiang, Liu, Tao, Liu, Song, Wong, Kwok K., Long, Mark D., Kufe, Donald
Publicado 2022

Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer

por Shah, Shruti D., Gillard, Bryan M., Wrobel, Michelle M., Karasik, Ellen, Moser, Michael T., Mastri, Michalis, Long, Mark D., Sule, Norbert, Brackett, Craig M., Huss, Wendy J., Foster, Barbara A.
Publicado 2023